Feb 3, 2021 Foresee Home AMD Monitoring Program Don’t leave your vision to chance: 94% of patients using ForeseeHome maintained driving vision (20/40 or better) after their dry Macular Degeneration changed to wet. Ask us if ForeseeHome is right for you. Please click here for more information about this program:https://www.foreseehome.com/ #DetectEarly #TreatEarly #ForeseeHome #MacularDegeneration Dec 3, 2024 Sun Pharma announces positive Phase 4 data results in dry eye disease Sun Pharma announces positive Phase 4 data results in dry eye disease Nov 27, 2024 Happy Thanksgiving Happy Thanksgiving Nov 22, 2024 Adverum reports positive 52-week, 4-year data for wet AMD gene therapy Adverum reports positive 52-week, 4-year data for wet AMD gene therapy